Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms Iodine-124-zelavespib + [2] |
Target |
Mechanism HSP90 modulators(Heat shock 90kDa proteins modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Marrow Neoplasms | Phase 1 | US | Samus Therapeutics LLCStartup | 01 Dec 2010 |
Bone Marrow Neoplasms | Phase 1 | US | 01 Dec 2010 | |
Non-Hodgkin Lymphoma | Phase 1 | US | 01 Dec 2010 | |
Non-Hodgkin Lymphoma | Phase 1 | US | Samus Therapeutics LLCStartup | 01 Dec 2010 |
Neoplasms | Discovery | - | Samus Therapeutics LLCStartup | - |
Neoplasms | Discovery | US | - | - |
Neoplasms | Discovery | - | - |